Treg cells share a common phenotype and TCR repertoire that confers multi-tissue migration, thus tissue Treg cells only maintain transient tissue residency and are tissue agnostic in rehoming assays Immunity Adrian Liston doi.org/10.1016/j.immu…

🚀 New scientific publication from DoCTIS! 📰 Check out the results from the #DoCTISProject in a new article on bioRxiv. Contributors include project partners CNAG, IDIBAPS, Vall d'Hebron Institut de Recerca, IMIDomics, Cardiff University, Università di Verona, & Charité - Universitätsmedizin Berlin. 🔬

👉 The full article, conducted in collaboration with Sara Marsal from Vall d'Hebron Institut de Recerca and Antonio Julià from IMIDomics, cam be found here: issuu.com/euresearcher/d…

🤒 #RheumatoidArthritis is one of six immune-mediated inflammatory diseases (#IMID) studied by the European #DocTISProject. 💊 While there's no cure, treatments can help ease symptoms, improve joint movement, and boost daily life. 👉 Learn more: doctis.eu/what-is-rheuma… #IMIDs

💥 The #DocTISProject has a brand-new website! 🆕 It features a more user-friendly design, with clearer navigation and engaging visual elements to make your experience even more enjoyable. 💖 We hope you like it! 👉 Visit: doctis.eu #DocTISProject #IMID #IMIDs

🤒 Curious about #CrohnsDisease? 🌟 This chronic condition causes digestive tract inflammation, with symptoms like pain, fatigue, and more. ❤️ echa rant plays a vital role by raising awareness. 👉 Learn more: doctis.eu/what-is-crohns… #DocTISProject

🌟 #DocTISProject data to be presented at Spain's National #Psoriasis Congress, organized by Academia Española de Dermatología y Venereología! 🩺 Dr. Carrascosa, Head of Dermatology at Hosp. Germans Trias, will share a study comparing psoriasis data from DocTIS with #atopicdermatitis. 📄 More info: congresopsoriasis.org

Checkpoint inhibitors not working in pancreatic cancer? By coactivating of Dectin-1 & CD40, macrophages, eradicated tumors, & induced immune memory in resistant models. Combination Therapy power unlocked. #DoCTIS #CombinationTherapy science.org/doi/10.1126/sc…

📣 #DocTISProject's General Assembly ended today with a presentation at Vall d'Hebron Hospital. ✨ Thanks to Dr. Begoña Benito Director of Vall d'Hebron Institut de Recerca, for joining us and emphasizing the project's significance, as well as to all attendees. Learn about DocTIS: doctis.eu

🎤 Meet Sandra Xiqués: member of the #DocTISProject Advisory Board living with #RheumatoidArthritis. In this interview, she shares her journey of balancing family & chronic illness challenges. 🔗 Full interview: doctis.eu/interview-sand… #IMID #IMIDs #IMIDResearch #PatientVoices

💊 #DocTISProject' clinical trials will start very soon! 🏥 📢 Learn from Dr. Ernest Choy of Cardiff University about how these trials were designed in this excerpt from the webinar “Discovery of Combination Therapies for Immune-Mediated Inflammatory Diseases”. #IMID #IMIDs

🚨 Antonio Julià's presentation at #Immunology2025, the annual meeting of The American Association of Immunologists (AAI), will be today, 5 May in Room 312 of HawaiiConventionCtr at 16:15 (Hawaii time!), featuring research from the #DocTISProject. Don't miss it! 👉 doctis.eu/doctis-researc… #Immunology #AAI2025 #IMID

🚀 Research from #DocTISProject presented at The American Association of Immunologists (AAI) annual meeting! 🔬 Dr Antonio Julià (Vall d'Hebron Institut de Recerca) attended #Immunology2025 to introduce key advances in identifying effective #drugcombinations for #IMIDs. 👉 More details: doctis.eu/combination-th… #Immunology #AAI2025 #IMID

🎤 “I was hoping for a positive pregnancy test and instead received a chronic illness diagnosis. I felt awful” ❤️ Meet Sandra Xiques, member of the #DocTISProject family, living with #RheumatoidArthritis. 🔗 Full interview: doctis.eu/interview-sand… #PatientVoices #IMID #IMIDs

✨ #DocTISProject at Soc.Esp.Reumatología's #SER2025 Congress. 📍 Vall d'Hebron Institut de Recerca presented 2 studies using multi-omics & systems biology to personalize treatments for #IMIDs, drawing strong interest and reinforcing DocTIS’ role in precision #rheumatology. 🔗 More: doctis.eu/doctis-congres…

🔬 Strong scientific interest in the #DocTISProject study at #EULAR2025! 🎙️ Antonio Julià from Vall d'Hebron Institut de Recerca presented a study to an engaged audience of around 80 attendees at the leading #Rheumatology event hosted by EULAR. 👉 Discover more here: doctis.eu/scientific-int… #EULAR

📣 Kicking off our #DocTISProject PI interview series with Britta Siegmund, from Charité - Universitätsmedizin Berlin: “Our disease-specific analyses have gone beyond the theoretical; they’ve led to real action”. 👉 Read more: doctis.eu/britta-siegmun… #IMID #IMIDs #Rheumatology #Gastroenterology

📣 In our latest PI interview, we speak with Giampiero Girolomoni, Head of the #Dermatology Section at Università di Verona: 🗨️ “I was captivated by the ambitious goals of the #DocTISProject”. 👉 Read more: doctis.eu/giampiero-giro… #IMID #IMIDs #AutoimmuneTherapies #IMIDResearch

Happy to share the partnering of IMIDomics with Formation Bio to advance our first-in-class anti-CD226 monoclonal antibody for immune-mediated inflammatory diseases. A big step towards our objective of delivering precision medicine! prnewswire.com/news-releases/…

🔬 Our #DocTISProject interview series continues! 🎤 Meet IMIDomics COO #ManuelLopezFigueroa: “DocTIS can reduce time to effective treatment, minimize side effects & improve long-term disease management”. 👉 Read more: doctis.eu/manuel-lopez-f… #IMID #IMIDs #IMIDResearch